Recursion Pharmaceuticals
clinical well understood clinical safety with a drug like profile further confidence prior studies suggestive of potential therapeutic benefit | Recursion Pharmaceuticals
Company
Deck Type
Sector
Industry
Deck date
January 2023
Slide
102 of 143
Related slides by other companies
Chimerix
Investor Presentation
May 2023
active in models of and other cancers ovarian cancer | Chimerix
Chimerix
Investor Presentation
March 2023
active in models of and other cancers | Chimerix
Aravive
Investor Presentation
September 2022
promising responses in patients in later lines of therapy and month platinum free interval compared to literature gas pathway a | Aravive
Chimerix
Investor Presentation
August 2023
active in models of and other cancers tumors non solid tumors endometrial cancer ovarian cancer | Chimerix
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io